$ICDIQ
Independence Contract Drilling, Inc. Stock $icdiq

$icdiq Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000153702823000023 Filed on May 09, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$56.36M	$63.76M	$34.99M
YoY Change	33.19%	82.21%	125.14%
Cost Of Revenue	$33.83M	$37.46M	$27.17M
YoY Change	17.03%	37.9%	86.83%
Gross Profit	$22.53M	$26.30M	$7.826M
YoY Change	68.01%	236.01%	682.6%
Gross Profit Margin	39.98%	41.24%	22.37%
Selling, General & Admin	$5.224M	$6.727M	$5.228M
YoY Change	7.49%	28.67%	41.83%
% of Gross Profit	23.19%	25.58%	66.8%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$11.41M	$10.85M	$9.751M
YoY Change	15.81%	11.31%	-2.39%
% of Gross Profit	50.62%	41.28%	124.6%
Operating Expenses	$16.63M	$6.727M	$5.228M
YoY Change	242.16%	28.67%	41.83%
Operating Profit	$5.900M	$8.729M	-$6.637M
YoY Change	-922.87%	-231.52%	-45.96%
Interest Expense	-$8.251M	-$8.719M	-$4.675M
YoY Change	0.23%	86.5%	26.04%
% of Operating Profit	-139.85%	-99.89%
Other Income/Expense, Net
YoY Change
Pretax Income	-$4.358M	$10.00K	-$59.52M
YoY Change	636.15%	-100.02%	272.18%
Income Tax	-$197.0K	-$2.000K	-$720.0K
% Of Pretax Income		-20.0%
Net Earnings	-$4.161M	$12.00K	-$58.80M
YoY Change	49.09%	-100.02%	266.9%
Net Earnings / Revenue	-7.38%	0.02%	-168.03%
Basic Earnings Per Share	-$0.30	$0.00	-$5.20
Diluted Earnings Per Share	-$0.30	$0.00	-$5.20
COMMON SHARES
Basic Shares Outstanding	14.06M	13.64M	11.30M
Diluted Shares Outstanding	14.05M	13.88M	11.30M

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.584M	$6.715M	$9.342M
YoY Change	-23.44%	-28.12%	73.0%
Cash & Equivalents	$5.584M	$6.715M	$9.342M
Short-Term Investments
Other Short-Term Assets	$2.732M	$1.000K	$9.000K
YoY Change	3448.05%	-88.89%	-99.8%
Inventory	$1.663M	$1.543M	$1.301M
Prepaid Expenses
Receivables	$34.51M	$41.84M	$24.23M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$44.49M	$53.97M	$39.42M
YoY Change	17.39%	36.89%	85.28%
LONG-TERM ASSETS
Property, Plant & Equipment	$374.9M	$380.1M	$360.0M
YoY Change	4.78%	5.58%	-4.17%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$832.0K	$2.389M	$2.201M
YoY Change	-60.66%	8.54%	-32.71%
Total Long-Term Assets	$375.7M	$381.1M	$361.0M
YoY Change	4.77%	5.58%	-4.26%
TOTAL ASSETS
Total Short-Term Assets	$44.49M	$53.97M	$39.42M
Total Long-Term Assets	$375.7M	$381.1M	$361.0M
Total Assets	$420.2M	$435.1M	$400.4M
YoY Change	5.97%	8.66%	0.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$18.30M	$26.95M	$18.83M
YoY Change	7.24%	43.15%	289.27%
Accrued Expenses	$7.137M	$13.55M	$10.55M
YoY Change	-21.09%	28.49%	11.33%
Deferred Revenue	$1.089M	$1.368M	$1.701M
YoY Change	335.6%	-19.58%	717.79%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.947M	$2.071M	$3.902M
YoY Change	-39.63%	-46.92%	-67.75%
Total Short-Term Liabilities	$32.06M	$42.57M	$33.28M
YoY Change	-11.61%	27.94%	26.04%
LONG-TERM LIABILITIES
Long-Term Debt	$155.2M	$163.9M	$120.1M
YoY Change	27.14%	36.47%	-9.7%
Other Long-Term Liabilities	$8.276M	$652.0K	$1.894M
YoY Change	318.61%	-65.58%	-28.66%
Total Long-Term Liabilities	$163.5M	$652.0K	$1.894M
YoY Change	8170.66%	-65.58%	-28.66%
TOTAL LIABILITIES
Total Short-Term Liabilities	$32.06M	$42.57M	$33.28M
Total Long-Term Liabilities	$163.5M	$652.0K	$1.894M
Total Liabilities	$207.5M	$219.4M	$251.2M
YoY Change	14.9%	-12.66%	51.81%
SHAREHOLDERS EQUITY
Retained Earnings	-$403.2M	-$399.1M	-$392.6M
YoY Change	1.99%	1.66%	38.67%
Common Stock	$619.9M	$618.7M	$545.7M
YoY Change	0.76%	13.37%	4.98%
Preferred Stock
YoY Change
Treasury Stock (at cost)			$3.923M
YoY Change			0.26%
Treasury Stock Shares			$81.85K
Shareholders Equity	$212.8M	$215.7M	$149.2M
YoY Change
Total Liabilities & Shareholders Equity	$420.2M	$435.1M	$400.4M
YoY Change	5.97%	8.66%	0.52%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$4.161M	$12.00K	-$58.80M
YoY Change	49.09%	-100.02%	266.9%
Depreciation, Depletion And Amortization	$11.41M	$10.85M	$9.751M
YoY Change	15.81%	11.31%	-2.39%
Cash From Operating Activities	$21.50M	$13.56M	-$1.661M
YoY Change	421.24%	-916.26%	-73.59%
INVESTING ACTIVITIES
Capital Expenditures	$12.33M	$18.84M	$6.279M
YoY Change	-310.9%	199.97%	260.45%
Acquisitions
YoY Change
Other Investing Activities	$798.0K	$748.0K	$589.0K
YoY Change	-42.71%	26.99%	-9.38%
Cash From Investing Activities	-$11.53M	-$18.09M	-$5.690M
YoY Change	158.95%	217.87%	422.98%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-11.10M	5.918M	12.55M
YoY Change	545.49%	-52.86%	2228.94%
NET CHANGE
Cash From Operating Activities	21.50M	13.56M	-1.661M
Cash From Investing Activities	-11.53M	-18.09M	-5.690M
Cash From Financing Activities	-11.10M	5.918M	12.55M
Net Change In Cash	-1.131M	1.389M	5.202M
YoY Change	-44.78%	-73.3%	-176.06%
FREE CASH FLOW
Cash From Operating Activities	$21.50M	$13.56M	-$1.661M
Capital Expenditures	$12.33M	$18.84M	$6.279M
Free Cash Flow	$9.167M	-$5.277M	-$7.940M
YoY Change	-8.05%	-33.54%	-1.15%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1508000
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	14062394
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2022Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001537028
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P9M
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2023Q1	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2023Q1	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-36590
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	Independence Contract Drilling, Inc.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	37-1653648
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	20475 State Highway 249
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 300
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Houston
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	77070
CY2023Q1	dei	City Area Code CityAreaCode	281
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	598-1230
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value per share
CY2023Q1	dei	Trading Symbol TradingSymbol	ICD
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6715000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5326000
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	31000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	41838000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	39775000
CY2023Q1	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1543000
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	63756000
CY2022Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	325000
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3871000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4736000
CY2023Q1	us-gaap	Assets Current AssetsCurrent	53967000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	51670000
CY2023Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	378703000
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	376084000
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2389000
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1960000
CY2023Q1	us-gaap	Assets Assets	435059000
CY2022Q4	us-gaap	Assets Assets	429714000
CY2023Q1	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	2071000
CY2022Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	2485000
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	26954000
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	31946000
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	13549000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	17608000
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	42574000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	52039000
CY2023Q1	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	163901000
CY2022Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	143223000
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	12253000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	12266000
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	652000
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7474000
CY2023Q1	us-gaap	Liabilities Liabilities	219380000
CY2022Q4	us-gaap	Liabilities Liabilities	215002000
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14147486
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13698851
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14062394
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13613759
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	141000
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	136000
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	618556000
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	617606000
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-399085000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-399097000
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	85092
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	85092
CY2023Q1	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	3933000
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	3933000
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	215679000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	214712000
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	435059000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	429714000
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	34991000
CY2023Q1	us-gaap	Direct Operating Costs DirectOperatingCosts	37460000
CY2022Q1	us-gaap	Direct Operating Costs DirectOperatingCosts	27165000
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6727000
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5228000
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	10854000
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	9751000
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	14000
CY2022Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	516000
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	55027000
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	41628000
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	8729000
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-6637000
CY2023Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-8719000
CY2022Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-4675000
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-46347000
CY2022Q1	icd	Change In Fair Value Of Embedded Derivative Liability ChangeInFairValueOfEmbeddedDerivativeLiability	1857000
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	10000
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-59516000
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2000
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-720000
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	12000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-58796000
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.20
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.20
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13865000
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11303000
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13881000
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11303000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	214712000
CY2023Q1	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	-385000
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-34000
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1374000
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	12000
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	215679000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	195229000
CY2022Q1	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	-32000
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3360000
CY2022Q1	icd	Stock Issued During Period Value Restructuring StockIssuedDuringPeriodValueRestructuring	9163000
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	292000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-58796000
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	149216000
CY2023Q1	us-gaap	Profit Loss ProfitLoss	12000
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-58796000
CY2023Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	10854000
CY2022Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	9751000
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1672000
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	731000
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	14000
CY2022Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	516000
CY2023Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	11619000
CY2022Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	3193000
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-46347000
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-727000
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	31000
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	27000
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	250000
CY2023Q1	icd	Amortization Of Convertible Notes Issuance Costs And Debt Discount AmortizationOfConvertibleNotesIssuanceCostsAndDebtDiscount	2378000
CY2022Q1	icd	Amortization Of Convertible Notes Issuance Costs And Debt Discount AmortizationOfConvertibleNotesIssuanceCostsAndDebtDiscount	370000
CY2022Q1	icd	Change In Fair Value Of Embedded Derivative Liability ChangeInFairValueOfEmbeddedDerivativeLiability	1857000
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-13000
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	60000
CY2023Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	2094000
CY2022Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	2079000
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	35000
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	130000
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-324000
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-386000
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-11203000
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2358000
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	13558000
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1661000
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	18835000
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6279000
CY2023Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	748000
CY2022Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	589000
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-18087000
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5690000
CY2022Q1	icd	Payments Of Merger Consideration PaymentsOfMergerConsideration	2902000
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-34000
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3360000
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	385000
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	32000
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	650000
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1194000
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5918000
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12553000
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1389000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	5202000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5326000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4140000
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6715000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9342000
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	419000
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	4262000
CY2023Q1	icd	Purchases Of Property Plant And Equipment In Accounts Payable PurchasesOfPropertyPlantAndEquipmentInAccountsPayable	-5091000
CY2022Q1	icd	Purchases Of Property Plant And Equipment In Accounts Payable PurchasesOfPropertyPlantAndEquipmentInAccountsPayable	-701000
CY2023Q1	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	51000
CY2022Q1	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	604000
CY2022Q1	icd	Finance Lease Extinguishment Of Lease Obligations From Sale Of Assets FinanceLeaseExtinguishmentOfLeaseObligationsFromSaleOfAssets	7000
CY2022Q1	icd	Initial Embedded Derivative Liability Upon Issuance Of Convertible Notes InitialEmbeddedDerivativeLiabilityUponIssuanceOfConvertibleNotes	75733000
CY2022Q1	icd	Non Cash Or Part Non Cash Expenses Restructuring Fees NonCashOrPartNonCashExpensesRestructuringFees	9163000
CY2022Q1	icd	Market Price Of Oil MarketPriceOfOil	123.64
CY2023Q2	icd	Market Price Of Oil MarketPriceOfOil	75.65
CY2022Q3	icd	Natural Gas Price NaturalGasPrice	9.85
CY2022Q4	icd	Natural Gas Price NaturalGasPrice	3.52
CY2023Q2	icd	Natural Gas Price NaturalGasPrice	2.24
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1158000
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	540000
CY2022Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	505000
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	31000.0
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	63756000
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	34991000
CY2023Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0
CY2023Q1	us-gaap	Contract With Customer Receivable After Allowance For Credit Loss ContractWithCustomerReceivableAfterAllowanceForCreditLoss	41849000
CY2022Q4	us-gaap	Contract With Customer Receivable After Allowance For Credit Loss ContractWithCustomerReceivableAfterAllowanceForCreditLoss	39732000
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1369000
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	967000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	751000
CY2023Q1	icd	Contract With Customer Liability Increase Decrease From Cash Receipts ContractWithCustomerLiabilityIncreaseDecreaseFromCashReceipts	751000
CY2022Q1	icd	Contract With Customer Liability Increase Decrease From Cash Receipts ContractWithCustomerLiabilityIncreaseDecreaseFromCashReceipts	1664000
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1365000
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	4000
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	0
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	0
CY2023Q1	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	700000
CY2022Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	300000
CY2023Q1	icd	Capitalized Contract Cost Increase CapitalizedContractCostIncrease	900000
CY2023Q1	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	500000
CY2022Q1	icd	Capitalized Contract Cost Increase CapitalizedContractCostIncrease	2000000.0
CY2022Q1	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	1200000
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	191000
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	194000
CY2023Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	1730000
CY2022Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	1397000
CY2023Q1	us-gaap	Variable Lease Cost VariableLeaseCost	162000
CY2022Q1	us-gaap	Variable Lease Cost VariableLeaseCost	123000
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	555000
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	315000
CY2023Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	73000
CY2022Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	114000
CY2023Q1	icd	Finance Lease Cost FinanceLeaseCost	628000
CY2022Q1	icd	Finance Lease Cost FinanceLeaseCost	429000
CY2023Q1	us-gaap	Lease Cost LeaseCost	2711000
CY2022Q1	us-gaap	Lease Cost LeaseCost	2143000
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	196000
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	186000
CY2023Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	73000
CY2022Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	113000
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	650000
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1194000
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	618000
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	51000
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	604000
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1435000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	976000
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	580000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	373000
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	134000
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1547000
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1124000
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	7358000
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	7307000
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	2596000
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	1994000
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	4762000
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	5313000
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2071000
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2485000
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1293000
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1599000
CY2023Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	3364000
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	4084000
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y9M18D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y7M6D
CY2023Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y4M24D
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y7M6D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0999
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1086
CY2023Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0811
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0812
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	837000
CY2023Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	1924000
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	673000
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	1121000
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	161000
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	560000
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	10000
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	9000
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1681000
CY2023Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	3614000
CY2023Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	250000
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1547000
CY2023Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	3364000
CY2022Q1	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	1900000
CY2022Q2	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	2400000
CY2022Q2	us-gaap	Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity	69200000
CY2022Q2	icd	Realized Gain On Extinguishment Of Derivative RealizedGainOnExtinguishmentOfDerivative	10800000
CY2022Q1	us-gaap	Debt Instrument Term DebtInstrumentTerm	P4Y
CY2023Q1	icd	Fair Value Assets Level Transfers Amount FairValueAssetsLevelTransfersAmount	0
CY2023Q1	us-gaap	Prepaid Insurance PrepaidInsurance	2406000
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	3796000
CY2023Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	785000
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	656000
CY2023Q1	us-gaap	Deferred Costs Current DeferredCostsCurrent	679000
CY2022Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	283000
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	1000
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1000
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3871000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4736000
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4692000
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6908000
CY2023Q1	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	1600000
CY2022Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	3002000
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1368000
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1003000
CY2023Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	2511000
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	3621000
CY2023Q1	us-gaap	Interest Payable Current InterestPayableCurrent	145000
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	101000
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	967000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	751000
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2266000
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2222000
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	13549000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	17608000
CY2023Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	3364000
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	4084000
CY2023Q1	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	203947000
CY2022Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	186061000
CY2023Q1	icd	Convertible Notes Issuance Costs And Debt Discount ConvertibleNotesIssuanceCostsAndDebtDiscount	37975000
CY2022Q4	icd	Convertible Notes Issuance Costs And Debt Discount ConvertibleNotesIssuanceCostsAndDebtDiscount	40353000
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2071000
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2485000
CY2023Q1	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	163901000
CY2022Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	143223000
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	39230000
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1672000
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	731000
CY2023Q1	icd	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Remaining Term To Maturity ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRemainingTermToMaturity	P4Y10M24D
CY2022	icd	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Remaining Term To Maturity ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRemainingTermToMaturity	P5Y1M6D
CY2023Q1	us-gaap	Shares Outstanding SharesOutstanding	14062394
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	85092
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	12000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-58796000
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.20
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.20
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13865000
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11303000
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13881000
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11303000
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4888000
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.200
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.012
CY2023Q1	us-gaap	Purchase Obligation PurchaseObligation	5100000
CY2022Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	78900000
CY2022Q1	icd	Investor S Rights Agreement Number Of Directors Who Can Be Nominated InvestorSRightsAgreementNumberOfDirectorsWhoCanBeNominated	1
CY2022Q1	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	25000000.0
CY2022Q1	icd	Investor S Rights Agreement Number Of Directors Who Can Be Nominated InvestorSRightsAgreementNumberOfDirectorsWhoCanBeNominated	1
CY2022Q1	icd	Number Of Holder Representatives That Have Right To Nominate Additional Representative As Director NumberOfHolderRepresentativesThatHaveRightToNominateAdditionalRepresentativeAsDirector	2
CY2022Q1	icd	Number Of Additional Representative To Be Appointed As Individual Director NumberOfAdditionalRepresentativeToBeAppointedAsIndividualDirector	1
CY2022Q1	icd	Number Of Holder Representatives That Have Right To Nominate Additional Representative As Director NumberOfHolderRepresentativesThatHaveRightToNominateAdditionalRepresentativeAsDirector	2
CY2022Q1	icd	Number Of Directors NumberOfDirectors	6
CY2022Q3	icd	Number Of Directors NumberOfDirectors	7

Files In Submission

Name	View Source	Status
icd-20230331_def.xml	Edgar Link	unprocessable
icd-20230331_pre.xml	Edgar Link	unprocessable
icd-20230331_cal.xml	Edgar Link	unprocessable
icd-20230331_lab.xml	Edgar Link	unprocessable
0001537028-23-000023-index-headers.html	Edgar Link	pending
0001537028-23-000023-index.html	Edgar Link	pending
0001537028-23-000023.txt	Edgar Link	pending
0001537028-23-000023-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
icd-20230331.xsd	Edgar Link	pending
icd-20230331x10q.htm	Edgar Link	pending
icd-20230331xex10d1.htm	Edgar Link	pending
icd-20230331xex10d2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
icd-20230331x10q_htm.xml	Edgar Link	completed
icd-20230331xex10d3.htm	Edgar Link	pending
icd-20230331xex10d4.htm	Edgar Link	pending
icd-20230331xex10d5.htm	Edgar Link	pending
icd-20230331xex31d1.htm	Edgar Link	pending
icd-20230331xex31d2.htm	Edgar Link	pending
icd-20230331xex32d1.htm	Edgar Link	pending
icd-20230331xex32d2.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ICDIQ
Independence Contract Drilling, Inc. Stock $icdiq

2023 Q2 Form 10-Q Financial Statement

#000153702823000023 Filed on May 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ICDIQ Independence Contract Drilling, Inc. Stock $icdiq

2023 Q2 Form 10-Q Financial Statement

#000153702823000023 Filed on May 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ICDIQ
Independence Contract Drilling, Inc. Stock $icdiq